Opportunity: In Vivo Imaging System For Explants Analysis
North America preclinical in-vivo imaging market estimated at USD 0.31 billion in 2016 and is projected to reach USD 0.4 billion by 2024, at a CAGR of 5% during the forecast period from 2016 to 2024.
Early detection of cancerous tumor requires the development of the contrast agent for LOIS (Laser Optoacoustic Imaging System) which can increase the preclinical and clinical application of this imaging. In Vivo Imaging System is designed to automate in vivo imaging research with one-touch, pre-set or user-defined PC controls for accurate, repeatable imaging. Capture superior images with the high resolution, high sensitivity cooled CCD camera and optics. UVP and AntiCancer, Inc. collaborated for fluorescent protein in vivo small animal imaging technology. UVP’s innovative world-class product “iBox Scientia” system provides researchers to access extensive techniques and applications technology from AntiCancer, Inc., equipping labs with comprehensive tools for small animal in vivo fluorescent imaging.
According to Goldstein Research, global in vivo imaging system market is categorized on the basis of product, application and end user. Products are further segmented into stand-alone NPWT devices, portable NPWT devices, single-use disposable NPWT devices, NPWT accessories (canisters). Single-use NPWT over conventional NPWT devices has evolved as a promising therapy and accounted for the market share of 45% in 2016 owing to cost-effective portability factors. In Europe, the in vivo imaging system devices market is forecast to rise from USD 0.50 billion in 2016 to USD 0.63 million by 2020, with an annual growth rate of 4.9%.
Global In Vivo Imaging System Industry Outlook, 2016-2024 covers the present ground scenario and future opportunity prospects for the market players to analyze the target markets across the globe. Moreover, the competitive analysis includes the in-depth analysis of the major players and leaders in the healthcare industry. The market study conducted on the basis of primary as well as secondary research where the analysts fragment the data from various databases such as Bloomberg, Factiva, Owler and others. Our primary research team conducted various interviews, surveys and group discussions of industry in vivo imaging system manufacturers, suppliers, and distributors, pharmaceutical companies, medical product manufacturers, healthcare institutions, clinical centres, medical research laboratories and academic medical centres and universities to analyze the future prospects of the overall healthcare industry.
Global In Vivo Imaging System Market Segmentation can be classified on the basis of:
In Vivo Imaging System Market By Technology
- Optical Imaging
- Bioluminescence Imaging
- Cerenkov Luminescence Imaging
- Nuclear Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computerized Tomography (SPECT)
- Magnetic Resonance Imaging (MRI)
- Digital Angiography
- Ultrasound
- Others (Ultrasound Imaging, Computerized Tomography)
In Vivo Imaging System Market By Application
- Monitoring Drug Treatment
- Tumor studies (Tumor Shedding, Tumor Angiogenesis, etc)
- Cancer research
- Heart disease
- Gene therapy
- Longitudinal Studies
In Vivo Imaging System Market By End Users
- Hospital/Clinics
- Pharmaceutical Research Institutes
- Diagnostic Laboratories
- Forensic Laboratories
- Educational research institutes
By Geography
- North America (US, Canada) In Vivo Imaging System Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) In Vivo Imaging System Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) In Vivo Imaging System Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Latin America (Brazil, Mexico and Rest of Latin America) In Vivo Imaging System Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) In Vivo Imaging System Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Market Trends, Drivers and Challenges
Public-private partnerships, foundations among the private entities launching partnerships or co-funding arrangements with government agencies are the key element of NIH roadmap initiative to support the particular project of medical devices these days. Joint ventured partnership is driving the value in current dynamic healthcare environment. In addition, collaboration of realizing new insights, new sources and new approaches is impacting the global in vivo imaging system market. The medical device industry is evolving from input based approach to value and outcome based approach is also the leading growth factor. However, global political uncertainties, sluggish economic outlook, restricted product folio, mandatory registrations for medical devices and high implementation and maintenance cost hinders the global in vivo imaging system market.
“Global In Vivo Imaging System Market Report” has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global In Vivo Imaging System market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.
Request Report Sample @ https://www.goldsteinresearch.com/request-sample/in-vivo-imaging-system-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024
About Goldstein Research
Based in U.S., Goldstein Research is a young business consulting and market research firm with vast reach across America, Asia and parts of Europe and the Middle East. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions. With 30+ domain experts and 50+ employees working day and night to crunch numbers and bring out the best and detailed market reports and forecasts, we strive to enable you to foresee upcoming market challenges and develop a robust business model and strategies, which would add to your profitability and market visibility as a brand.
Media Contact
Company Name: Goldstein Research
Contact Person: Steve Blade
Email: stevebladeusa@gmail.com
Phone: +1-6465687747
Address:99 Wall Street, Suite No:- 527
City: New York,
State: NY
Country: United States
Website: http://www.goldsteinresearch.com/